Skip to main content
. 1999 Jul;6(4):494–498. doi: 10.1128/cdli.6.4.494-498.1999

FIG. 2.

FIG. 2

Antibodies with specificities to HLA class I (solid bars) or class II (shaded bars) molecules inhibit HPV-16 E6- and E7-specific responses. The results at the effector-to-target ratio of 50 to 1 are shown.